Patent Prosecution

In today’s innovation-driven economy, a strong patent portfolio does more than protect inventions—it protects your company’s future. Securing that protection is about more than filing applications—it is about safeguarding your company’s competitive position and long‑term growth. Our team includes registered U.S. patent attorneys with extensive experience across all major technologies and industries, combining law firm and in‑house perspectives to build, defend, and monetize patent assets worldwide. Drawing on a background in STEM, we help clients transform complex science into durable, enforceable patent rights that support real business outcomes. We partner with emerging companies, Fortune 500 corporations, and sophisticated investors to file first applications, manage extensive global portfolios, and monetize innovation through licensing and transactions.

Our patent attorneys are widely recognized for prosecution and counseling work in and out of court, including rankings in leading directories such as Chambers USA, Best Lawyers in America, IP Stars, and Super Lawyers.

We represent clients across the full spectrum of life sciences and related technologies, including:

• Medical devices, drug–device combinations, and digital health technologies
• Mechanical systems and industrial technologies
• Electrical engineering and computer hardware
• Computer software, AI, telecommunications, wireless, and Internet of Things (IoT) technologies
• Biologicals and biosimilars, vaccines and adjuvants, and molecular diagnostics
• Pharmaceuticals, nutraceuticals, agrochemicals, specialty and fine chemicals, and consumer products
• Process manufacturing, polymers, and complex chemical compositions

This breadth of experience enables us to quickly understand your science, identify protectable innovations, and design prosecution strategies aligned with product lifecycles and regulatory pathways.

We handle the full range of patent counseling, preparation, and prosecution work, both in the United States and abroad. Our services include:

• Patentability assessments, prior art research, and competitive landscape analyses in U.S. and foreign jurisdictions
• Drafting and prosecuting U.S., PCT, and foreign patent applications for complex chemical, pharmaceutical, and device technologies
• Coordinating global filing and prosecution strategies with foreign associates to secure consistent, efficient protection in key markets
• Managing post‑grant proceedings before the Patent Trial and Appeal Board (PTAB), including reexaminations and post‑grant reviews
• Lifecycle management (LCM), including patent‑term strategies, follow‑on filings, and patent-thicket design around core assets
• Strategic portfolio management, including identifying licensing opportunities to expand market coverage and monetize underutilized patents

At each stage, we focus on building records that support enforceability, survive validity challenges, maximize portfolio value, and streamline communications with the USPTO and foreign patent offices. We also understand the pressures of managing internal and external resources, and we balance meticulous preparation with efficient execution so your team can focus on innovation.

Our prosecution work is informed by decades of litigation and opinion experience, including ANDA Hatch‑Waxman litigation and complex life‑sciences disputes. We routinely:​​

• Conduct freedom‑to‑operate (FTO) and clearance analyses to guide product selection, formulation, and launch strategies
• Prepare formal non‑infringement and invalidity opinions that support risk‑managed decision‑making and negotiations
• Advise on design‑around strategies, competitive intelligence, and pre‑suit investigations

We emphasize prevention and early resolution, using insight from years of contested matters to design proactive measures that reduce risk before disputes arise.

When disputes do occur, we act swiftly, focusing on effective, efficient resolutions while preserving and enforcing our clients’ key patent positions.

We recognize that patents are financial assets as much as legal rights. Leveraging advanced training in finance, valuation, and statistics, we help clients:​

• Prioritize and plan portfolios around core technologies, key markets, and anticipated revenue streams
• Evaluate patents and portfolios for transactions, licensing, M&A, and litigation finance
• Develop financial models, damage frameworks (lost profits, reasonable royalties, price erosion, unjust enrichment), and valuation analyses that tie patent strategy to business performance

Our work with multinational and domestic companies, financial institutions, and emerging growth companies enables us to tailor portfolio strategies to diverse capital structures and business models.​​

We coordinate worldwide prosecution for multinational corporations, mid‑cap and small‑cap companies, startups, universities, research institutes, financial institutions, and solo inventors. We act as an extension of your team, collaborating closely with in‑house counsel, technical leaders, and subject‑matter experts to align global filing and prosecution strategies with your business goals. By partnering closely with foreign firms and local counsel, we harmonize claim scope, manage cost, and ensure that your IP strategy reflects the legal and commercial realities of each jurisdiction in which you operate.

Effective, defensible patent protection begins with strategic prosecution and continues through portfolio management and enforcement. We have helped clients secure and enhance high‑value patent rights across a range of technologies, including:

• Genome editing and CRISPR‑Cas9 technologies: We played a key role in negotiating multiple global license agreements and research collaborations, helping our client secure critical rights under foundational patents while preserving future flexibility in important fields of use.
• Industrial and high‑tech portfolios: We guided multiple patents through reexamination and related proceedings for a global industrial client, maintaining coverage for past damages while strengthening claim sets to support favorable settlements and licensing outcomes.
• We drafted multiple patents covering NDA products that have been listed in the Orange Book and, to date, have not been successfully challenged or designed-around.